Fasting mimicking diet reduces risk factors for aging and multiple age-related disease
A randomized Phase II clinical trial demonstrated that ProLon targets the aging process, reducing risk factors for age-related diseases such as diabetes, cancer, and cardiovascular disease in humans. The study found significant reductions in body weight, BMI, total body fat, and inflammation, while increasing relative lean body mass.